GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection

Authors:
  • HWHeiner Wedemeyer
    Heiner Wedemeyer
  • KSKatrin Schöneweis
    Katrin Schöneweis
  • PBPavel O. Bogomolov
    Pavel O. Bogomolov
  • NVNatalia Voronkova
    Natalia Voronkova
  • VCVladimir Chulanov
    Vladimir Chulanov
  • TSTatyana Stepanova
    Tatyana Stepanova
  • BBBirgit Bremer
    Birgit Bremer
  • LALena Allweiss
    Lena Allweiss
  • MDMaura Dandri
    Maura Dandri
  • JBJürgen Burhenne
    Jürgen Burhenne
  • WHWalter-Emil Haefeli
    Walter-Emil Haefeli
  • SCSandra Ciesek
    Sandra Ciesek
Publisher website
Google Scholar
Abstract
No abstract available